| Karen R Ringwald, MD | |
|
7916 W Jefferson Blvd, Fort Wayne, IN 46804-4140 | |
| (260) 432-2297 | |
| (260) 434-6392 |
| Full Name | Karen R Ringwald |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 25 Years |
| Location | 7916 W Jefferson Blvd, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922075084 | NPI | - | NPPES |
| P00783758 | Other | IN | RAILROAD MEDICARE |
| 2493145 | Medicaid | OH | |
| 200309590 | Medicaid | IN | |
| 000000331980 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 01055867A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Regional Medical Center | Fort wayne, IN | Hospital |
| Kosciusko Community Hospital | Warsaw, IN | Hospital |
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Dupont Hospital Llc | Fort wayne, IN | Hospital |
| Adams Memorial Hospital | Decatur, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lutheran Medical Group Llc | 4981751617 | 261 |
News Archive
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
Drug discovery could be significantly accelerated thanks to a new high precision machine-learning model, developed by an international collaboration of researchers, including the University of Warwick.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis, a chronic, debilitating disorder that damages myelin forming cells in the brain and spinal cord.
Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.
› Verified 2 days ago
| Entity Name | Lutheran Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164662805 PECOS PAC ID: 4981751617 Enrollment ID: O20090414000705 |
News Archive
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
Drug discovery could be significantly accelerated thanks to a new high precision machine-learning model, developed by an international collaboration of researchers, including the University of Warwick.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis, a chronic, debilitating disorder that damages myelin forming cells in the brain and spinal cord.
Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen R Ringwald, MD 6920 Pointe Inverness Way Ste 200, Fort Wayne, IN 46804-7934 Ph: (260) 479-3514 | Karen R Ringwald, MD 7916 W Jefferson Blvd, Fort Wayne, IN 46804-4140 Ph: (260) 432-2297 |
News Archive
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
Drug discovery could be significantly accelerated thanks to a new high precision machine-learning model, developed by an international collaboration of researchers, including the University of Warwick.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis, a chronic, debilitating disorder that damages myelin forming cells in the brain and spinal cord.
Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.
› Verified 2 days ago
Dr. Dustin M Thomas, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11108 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-5700 Fax: 260-266-5910 | |
Ahmad Alhariri, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-2020 | |
Dr. Anuradha G Bommakanti, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-7001 | |
Eileen Jill Ramos Muzzillo, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4402 E State Blvd, Fort Wayne, IN 46815 Phone: 260-425-5600 Fax: 260-425-5605 | |
John T Ducker, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7836 W Jefferson Blvd, Suite 101, Fort Wayne, IN 46804 Phone: 260-494-3484 Fax: 260-969-0188 | |
Mr. Kenneth A Smith, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1234 East Dupont Road, Suite 5, Fort Wayne, IN 46825 Phone: 260-489-1666 Fax: 260-489-3255 | |
Dr. Carl Marc Williams, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr, Fort Wayne, IN 46845 Phone: 260-373-9700 Fax: 260-373-9740 |